UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027503
Receipt number R000031286
Scientific Title A clinical study for evaluating the effects of maltitol on improving liver function
Date of disclosure of the study information 2018/09/30
Last modified on 2019/05/30 13:38:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study for evaluating the effects of maltitol on improving liver function

Acronym

A clinical study for evaluating the effects of maltitol on improving liver function

Scientific Title

A clinical study for evaluating the effects of maltitol on improving liver function

Scientific Title:Acronym

A clinical study for evaluating the effects of maltitol on improving liver function

Region

Japan


Condition

Condition

None

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of maltitol intake for 12 weeks on improving liver function

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AST and ALT (0w, 4w, 8w, 12w)

Key secondary outcomes

Fatty liver grade determined by abdominal ultrasonography (12w)
Body fat percentage (0w, 4w, 8w, 12w)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of the capsules containing low-dose maltitol for 12 weeks

Interventions/Control_2

Intake of the capsules containing high-dose maltitol for 12 weeks

Interventions/Control_3

Intake of the placebo capsules for 12 weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Healthy subjects aged from 20 to 65 years old
2) Subjects whose serum AST or ALT is 31 IU/L or more and 50 IU/L or less
3) Subjects whose BMI is 18.5 kg/m2 or more and less than 30 kg/m2
4) Subjects who have a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Key exclusion criteria

1) Subjects receiving treatment for fatty liver
2) Subjects receiving treatment for diabetes or dyslipidemia
3) Subjects with suspicion of cirrhosis of the liver
4) Subjects with suspicion of viral hepatitis
5) Subjects with a heavy alcohol consumption (>=30 g/day for men, >=20 g/day for women)
6) Subjects who have severe liver, cardiovascular, respiratory, endocrine or metabolic diseases
7) Subjects who have the possibility of developing allergic symptoms by the test food
8) Subjects who are during pregnancy or lactation, and intend to be pregnant during the study period.
9) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months (e.g. donated blood) prior to the start of the present study
10)Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study
11) Subjects deemed unsuitable by the investigator

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiro Fukuda

Organization

Fukuda Clinic

Division name

Director

Zip code


Address

Shin-Osaka Brick Building 2F, 1-6-1, Miyahara, Yodogawa-ku, Osaka, Osaka

TEL

06-6398-0203

Email

fukuda@drmog.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomohiro Sugino

Organization

Soiken Inc.

Division name

Representative Director

Zip code


Address

Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka

TEL

06-6871-8888

Homepage URL


Email

sugino@soiken.com


Sponsor or person

Institute

Soiken Inc.

Institute

Department

Personal name



Funding Source

Organization

UENO FOOD TECHNO INDUSTRY, LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人弘正会ふくだ内科クリニック(大阪府)


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 18 Day

Date of IRB

2017 Year 02 Month 18 Day

Anticipated trial start date

2017 Year 05 Month 27 Day

Last follow-up date

2017 Year 09 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 05 Month 26 Day

Last modified on

2019 Year 05 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031286


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name